Molecular Cancer

official impact factor 3.78

Open Access Highly Access

The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention

John P Alao

Molecular Cancer 2007, 6:24 doi:10.1186/1476-4598-6-24

Accesses  

  • Last 30 days: 589 accesses
  • Last 365 days: 5789 accesses
  • All time: 24774 accesses

Cited by

BioMed Central: 4 citations

Research   Open Access

Cyclin D1 expression in colorectal cancer is a favorable prognostic factor in men but not in women in a prospective, population-based cohort study

Sakarias Wangefjord, Jonas Manjer, Alexander Gaber, Björn Nodin, Jakob Eberhard, Karin Jirström Biology of Sex Differences 2011, 2:10 (3 September 2011)

Short report   Open Access Highly Accessed

The ATM and ATR inhibitors CGK733 and caffeine suppress cyclin D1 levels and inhibit cell proliferation

John P Alao, Per Sunnerhagen Radiation Oncology 2009, 4:51 (10 November 2009)

Research   Open Access

Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer

Nassima Redjimi, Françoise Gaudin, Cyril Touboul, Dominique Emilie, Marc Pallardy, Armelle Biola-Vidamment, Hervé Fernandez, Sophie Prévot, Karl Balabanian, Véronique Machelon Molecular Cancer 2009, 8:83 (8 October 2009)

Research article   Open Access

P53 expression is significantly correlated with high risk of malignancy and epithelioid differentiation in GISTs. An immunohistochemical study of 104 cases

Ursula Pauser, Nina Schmedt auf der Günne, Günter Klöppel, Hartmut Merz, Alfred C Feller BMC Cancer 2008, 8:204 (23 July 2008)